首页> 外文OA文献 >The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

【2h】

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

机译：每日一次美金刚胺（28 mg）的安全性，耐受性和功效：接受胆碱酯酶抑制剂的中重度阿尔茨海默氏病患者的多国，随机，双盲，安慰剂对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
George T. Grossberg; Facundo Manes; Ricardo F. Allegri; Luis Miguel Gutiérrez-Robledo; Sergio Gloger; Lei Xie; X. Daniel Jia; Vojislav Pejović; Michael L. Miller; James L. Perhach; Stephen M. Graham;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. The safety, tolerability, and efficacy of once-daily memantine (28 mg): A multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe alzheimer's disease taking cholinesterase inhibitors [J] . GrossbergG.T., ManesF., AllegriR.F., CNS drugs . 2013,第6期

机译：每日一次美金刚（28 mg）的安全性，耐受性和疗效：一项针对胆碱酯酶抑制剂的中重度阿尔茨海默氏病患者的多国，随机，双盲，安慰剂对照试验
2. Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: Results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan [J] . NakamuraY., KitamuraS., HommaA., Expert opinion on pharmacotherapy . 2014,第7期

机译：美金刚对中度至重度阿尔茨海默氏病患者的疗效和安全性：日本两项随机，双盲，安慰剂对照试验的汇总分析结果
3. Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial [J] . Seong-Ho Koh, Hyuk Sung Kwon, Seong Hye Choi, Alzheimer s Research & Therapy . 2021,第1期

机译：GV1001在中度至重度的阿尔茨海默病患者中的疗效和安全性已经接受过奈哌齐：A相随机，双盲，安慰剂控制，多中心临床试验
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. The Safety Tolerability and Efficacy of Once-Daily Memantine (28 mg): A Multinational Randomized Double-Blind Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors [O] . George T. Grossberg, Facundo Manes, Ricardo F. Allegri, -1

机译：每日一次美金刚胺（28 mg）的安全性耐受性和功效：针对中度至重度阿尔茨海默氏病患者服用胆碱酯酶抑制剂的多国性随机双盲安慰剂对照试验
7. The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial [O] . Christopher L.H. Chen, Purabi Reang Sharma, Boon Yeow Tan, 2019

机译：Lzheimer的疾病与Ne Uroaid（Athene）的研究方案的脱脂剂：评估神经外套II（MLC901）在胆碱酯酶抑制剂或Memantine-A随机的双盲患者稳定的患者中神经外套II（MLC901）的安全性和有效性安慰剂对照试验

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅